№ files_lp_4_process_3_059357
File format: docx
Character count: 2662
File size: 74 KB
This document is a consent form for participants in the Prevalence of Pathogenic Antibodies in Psychosis 2 (PPiP2) study, outlining the voluntary nature of participation and the conditions for data use and confidentiality.
Study title:
Prevalence of Pathogenic Antibodies in Psychosis 2 (PPiP2)
Principal Investigator:
Local PPiP2 researcher
Participant study ID:
[ID]
Date:
[Date]
Version:
[Version]
Year:
[Year]
Region / City:
[Region or city if mentioned]
Topic:
Medical Research, Psychiatric Studies
Document Type:
Consent Form
Institution:
University of Oxford
Author:
[Author(s) if available]
Target Audience:
Research Participants, Medical Professionals
Study Period:
[Study Period if mentioned]
Approval Date:
[Date of approval if mentioned]
Amendment Date:
[Date of amendments if mentioned]
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Year
Topic:
Avian Influenza, Biosecurity
Document Type:
Response Plan
Organization / Institution:
Iowa Department of Agriculture and Land Stewardship (IDALS)
Author:
Iowa Poultry Association, United States Department of Agriculture (USDA)
Target Audience:
Poultry Industry, Veterinarians, Government Agencies
Period of Validity:
Ongoing
Note:
Gene
Year:
2020
Region / city:
Not specified
Topic:
Genetic variants, Germline mutations
Document type:
Supplementary Table
Author:
Matejcic et al
Target audience:
Researchers in genetics, oncology
Period of validity:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Year:
2026
Region:
Delaware, United States
Topic:
Avian Influenza Control and Surveillance
Document Type:
Situation Update / Government Notice
Agency:
Delaware Department of Agriculture
Affected Population:
Commercial and backyard poultry flocks
Date of Release:
February 2, 2026
Control Area Status:
Released for non-infected premises within 10 km radius
Quarantine Status:
Infected farm remains under quarantine
Health Advisory:
Biosecurity measures recommended for all flocks on Delmarva Peninsula
Previous Case Announcement:
January 10, 2026, presumptive positive in Kent County commercial flock
Contact Information:
Delaware Poultry Health Hotline, [email protected], 302-698-4507
Year:
2026
Region / City:
Tamil Nadu, India
Topic:
Antibiotic resistance in environmental bacteria
Document Type:
Research article
Institution:
Local environmental and microbiology laboratory
Author:
Not specified
Target Audience:
Microbiologists, environmental scientists, public health professionals
Study Period:
2025–2026
Sampling Sites:
S1, S2, S3, S4 of Poondi Lake
Methods:
Sediment collection, bacterial isolation, biochemical identification, antibiotic susceptibility testing
Key Findings:
Presence of Shigella spp., Salmonella spp., Proteus spp., and Acinetobacter spp. with multi-drug resistance
Keywords:
Sediment, Antibiotic resistance bacteria, Multi-drug resistance, Environmental bacteria, Antibiotic susceptibility test
Description:
Research article detailing the prevalence and antibiotic resistance patterns of pathogenic bacteria isolated from lake sediments, including multi-drug resistant strains identified through culture and biochemical tests.
Version:
2.1
Executive Lead:
Executive Director of Quality and Medical Leadership
Lead Author:
Principal Clinical Pharmacist
Approved Date:
14/11/2022
Approved By:
Drugs and Therapeutics Committee (DTC)
Ratified Date:
14/11/2022
Ratified By:
Drugs and Therapeutics Committee (DTC)
Issue Date:
08/02/2023
Expiry Date:
14/11/2025
Target Audience:
Clinical staff
Document Type:
Guidelines
Ratifying Committee:
Drugs and Therapeutics Committee (DTC)
Review Date:
14/11/2025
Summary of significant changes from previous version:
Minor amendments: References to Xeplion® LAI in the document changed to Paliperidone monthly LAI as generic version available
Purpose:
Provide clinical staff with clear guidance on prescribing antipsychotics for the management of psychosis / schizophrenia in adults.
Document Type:
Application form
Programme Name:
Living Well with Psychosis community funding call
Submission Method:
Online grants management system SmartSimple
Subject Area:
Severe enduring mental illness
Relevant Conditions:
Schizophrenia, bipolar disorder, post-traumatic stress disorder
Maximum Funding Duration:
18 months
Target Applicants:
Organisations working with people affected by severe enduring mental illness
Required Information:
Applicant details, project summary, funding request, organisational experience, governance involvement
Financial Information Requested:
Total funding requested and intended use of funds
Geographical Scope:
Boroughs specified by applicant
Decision-Making Criteria Reference:
Eligibility and scoring criteria
Year:
2016
Region / city:
United Kingdom
Topic:
Safety seeking behaviours, psychosis, anxiety
Document type:
Research article
Institution:
The University of Manchester, The Psychosis Research Unit, Greater Manchester West Mental Health NHS Foundation Trust
Author:
Sarah Tully, Adrian Wells, Anthony P. Morrison
Target audience:
Researchers, mental health professionals
Period of validity:
N/A
Approval date:
N/A
Date of changes:
N/A
Year:
Not specified
Region / city:
Not specified
Topic:
Mental health, psychosis
Document type:
Research article
Organization / institution:
Not specified
Author:
Not specified
Target audience:
Researchers, mental health professionals
Period of validity:
Not specified
Approval date:
Not specified
Date of modifications:
Not specified
Contextual description:
Research article analyzing demographic characteristics and interview features used to identify individuals at clinical high risk for psychosis and community controls.
Year:
Not specified
Region / City:
Not specified
Topic:
Neurological Disorders, Psychiatry, Neuroimaging
Document Type:
Scientific Supplementary Figure
Organization / Institution:
Not specified
Author:
Not specified
Target Audience:
Researchers, Clinicians
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Contextual Description:
A scientific supplement detailing post-hoc comparisons of FAT and FW between healthy controls, adolescent-onset schizophrenia, and adolescent-onset bipolar disorder with psychosis, using neuroimaging data.
Year:
2023
Region / City:
Global
Topic:
Mental Health, Psychosis, Schizophrenia
Document Type:
Research Protocol / Search Strategy
Organization:
N/A
Author:
N/A
Target Audience:
Researchers, Mental Health Professionals
Effective Period:
N/A
Approval Date:
N/A
Revision Date:
N/A
Keywords:
psychosis, schizophrenia, risk, treatment, early intervention, qualitative research, search strategy
Year:
2026
Organization:
The Royal College of Psychiatrists
Position:
Patient Representative or Carer Representative
Salary:
£140 per day
Contract Type:
3-Year Fixed Term
Location:
United Kingdom
Application Submission:
Email to [email protected]
Target Audience:
Applicants with relevant experience in patient or carer advocacy
Relevant Legislation:
Equality Act 2010
Member Programs:
Disability Confident employer scheme
Required Documents:
CV, Cover Letter, Diversity Monitoring Form
Year:
2025
Region / City:
United Kingdom
Topic:
Mental health, risk assessment
Document type:
Research study with supplementary materials
Institution:
Early Intervention in Psychosis Services
Authors:
Multiple clinicians and researchers
Target audience:
Mental health professionals
Study period:
12 months
Assessment tool:
Oxford Mental Illness and Violence (OxMIV)
Methodology:
Mixed methods (quantitative assessments and qualitative interviews)
Participants:
Clinicians and patients with carers
Supplementary materials:
OxMIV assessment data, clinician and patient characteristics, thematic analysis of interviews